Internal Medicine, Rheumatology · Greenville, NC
NPI
1972506921
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
1850 W Arlington Blvd
Greenville, NC, 27834
Phone (252) 752-6101
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
134,904 services
Medicare patients, 2024
1,468
Average age 74
Drug cost, 2024
$4.3M
6,455 prescriptions
Company payments, 2025
$488
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Duncan Fagundus was code J0129 (injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 19,201 times for 29 patients. In total Duncan Fagundus billed 134,904 services in 161 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-09.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 19,201 | 29 | $33.43 | $642K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 12,570 | 43 | $24.82 | $312K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 11,650 | 15 | $9.08 | $106K |
| J0897 Injection, denosumab, 1 mg | Office | 8,940 | 94 | $20.60 | $184K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,599 | 72 | $0.10 | $658 |
| J9312 Injection, rituximab, 10 mg | Office | 3,400 | 12 | $61.31 | $208K |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 1,167 | 28 | $0.23 | $265 |
| 99214 Office E&M - Established | Office | 985 | 482 | $89.64 | $88K |
| 85025 Blood Count | Office | 823 | 318 | $7.58 | $6,242 |
| 36415 Venipuncture Blood Collection | Office | 803 | 374 | $8.64 | $6,938 |
| 80076 Clinical Chemistry | Office | 718 | 258 | $7.97 | $5,724 |
| 82565 Clinical Chemistry | Office | 701 | 272 | $5.01 | $3,509 |
| 96372 Injection Administration | Office | 438 | 148 | $10.39 | $4,549 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 436 | 52 | $0.75 | $329 |
| 99213 Office E&M - Established | Office | 432 | 305 | $61.78 | $27K |
By year: 2022 $2.2M for 120,997 services; 2023 $2.1M for 115,612 services; 2024 $2.1M for 134,904 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 823 | 318 | $7.58 | $6,242 |
| 36415 Venipuncture Blood Collection | 803 | 374 | $8.64 | $6,938 |
| 80076 Clinical Chemistry | 718 | 258 | $7.97 | $5,724 |
| 82565 Clinical Chemistry | 701 | 272 | $5.01 | $3,509 |
| 86140 Clinical Chemistry | 275 | 192 | $5.08 | $1,397 |
| 86480 Immunoassay | 136 | 131 | $60.55 | $8,235 |
| 86235 Immunoassay | 119 | 17 | $17.57 | $2,091 |
| 82306 Clinical Chemistry | 80 | 78 | $29.01 | $2,321 |
| 82310 Clinical Chemistry | 56 | 54 | $5.06 | $283 |
| 80053 Clinical Chemistry | 56 | 51 | $10.35 | $580 |
Medicare prescription drug claims, 2024
In 2024, the drug Duncan Fagundus prescribed most often to Medicare patients was Prednisone, with 1,216 prescriptions and refills. In total Duncan Fagundus wrote 6,455 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 1,216 | 1,923 | 280 | $7,563 |
| Methotrexate Methotrexate Sodium | 772 | 1,527 | 186 | $12K |
| Hydroxychloroquine Sulfate Generic | 466 | 1,029 | 127 | $14K |
| Gabapentin Generic | 416 | 654 | 96 | $4,922 |
| Celecoxib Generic | 264 | 467 | 68 | $5,485 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 193 | 193 | 56 | $3,698 |
| Methylprednisolone Generic | 188 | 254 | 93 | $2,079 |
| Meloxicam Generic | 187 | 286 | 48 | $810 |
| Duloxetine Hcl Generic | 181 | 333 | 44 | $2,096 |
| Allopurinol Generic | 178 | 448 | 49 | $1,625 |
| Cyclobenzaprine Hcl Generic | 158 | 184 | 50 | $667 |
| Tramadol Hcl Generic | 154 | 157 | 56 | $1,085 |
| Alendronate Sodium Generic | 154 | 328 | 46 | $1,095 |
| Leflunomide Generic | 123 | 260 | 33 | $5,794 |
| Trazodone Hcl Generic | 112 | 150 | 18 | $688 |
Brand drugs: - claims; generic drugs: 5,773 claims; opioid claims: 414.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Duncan Fagundus $488 ($488 in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $353.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.